Compositions and Methods for Stimulating Antigen-Specific Immune Responses and Preventing Disease
This technology is a catanionic surfactant vesicle designed to boost the immune system to protect against infections and diseases like cancer.
Background
Developing robust methods to elicit a protective and lasting immune response is fundamental for preventing infectious diseases and for treating complex, life-threatening conditions.
However, many existing vaccines and immunotherapies struggle to generate sufficiently potent or durable immunity, especially against highly mutable pathogens or the intricate evasive strategies employed by cancer cells. These challenges often stem from issues such as suboptimal antigen presentation, inadequate activation of key immune cell populations, or the necessity for frequent booster administrations to sustain protection. Additionally, some therapies may induce undesirable systemic side effects or lack the precise targeting required, thereby limiting their broad utility and efficacy across diverse patient demographics.
Technology
Catanionic surfactant vesicles composed of unilamellar bilayer comprising a mixture of oppositely charged single-tailed surfactants and one or a plurality of immunogens represent a powerful vaccine adjuvant. This technology is a novel composition, including pharmaceutical formulations and vaccines, designed to elicit a precise immune response against various pathogens and cancers. The approach harnesses the body’s immune system to combat health threats.
Benefits
- Stimulates antigen-specific immune response
- Provides protective immune response against pathogens
- Useful for treatment and prevention of diseases
- Applicable in cancer therapy
- Can be formulated as vaccines or pharmaceutical compositions
Applications
- Personalized cancer immunotherapy
- Infectious disease vaccines
- Veterinary vaccines
- Prophylactic immunization programs
Additional info
Publications:
Evaluating methods to create protein functionalized catanionic vesicles. Soft Matter. 2023 Feb 15;19(7):1429-1439 Zayka P, Parr B, Robichaud H, Hickey S, Topping A, Holt E, Watts DBE, Soto N, Stein DC, DeShong P, Hurley M.
Extraction of Membrane Components from Neisseria gonorrhoeae Using Catanionic Surfactant Vesicles: A New Approach for the Study of Bacterial Surface Molecules. Pharmaceutics. 2020 Aug 20;12(9):787. Stein DC, H Stocker L, Powell AE, Kebede S, Watts D, Williams E, Soto N, Dhabaria A, Fenselau C, Ganapati S, DeShong P.